NFKB1 and diabetic kidney disease: Genetic ablation of HSPA8 in TECs activates SREBP signaling pathways, while hyperglycemic conditions mimicking DKD pathophysiology reduce HSPA8 expression through NF-κB-mediated transcriptional repression [14].